Dawaa Reference

chronic

Neoplasm of the Ear

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources2 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class HD25 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

An umbrella code for any ear growth of unspecified behaviour; the GP's role is recognising a mass and referring for biopsy and specialist assessment, not prescribing. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

An umbrella code for any ear growth of unspecified behaviour; the GP's role is recognising a mass and referring for biopsy and specialist assessment, not prescribing.

Cautions
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Rapid growth, bleeding or ulceration, or associated facial nerve weakness or hearing loss: refer urgently.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.